Gary S Jacob Hepion Pharmaceuticals, Inc. (HEPA) insider trading activity

HEPA Quotes by TradingView

Gary S Jacob is Director of Hepion Pharmaceuticals, Inc.. Currently has a direct ownership of 12,059 shares of HEPA, which is worth approximately $8,923. The most recent transaction as insider was on Dec 01, 2020, when has been sold 12,000 shares (Common Stock) at a price of $1.66 per share, resulting in proceeds of $19,920. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.1K
0% 3M change
0% 12M change
Total Value Held $8,923

GARY S JACOB Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2020
BUY
Open market or private purchase
$19,920 $1.66 p/Share
12,000 Added 49.88%
12,059 Common Stock

Also insider at

CRDF
Cardiff Oncology, Inc. Healthcare
VRPX
Virpax Pharmaceuticals, Inc. Healthcare
Director
OKYO
OKYO Pharma Ltd Healthcare
Chief Executive Officer
GSJ

Gary S Jacob

Director
Edison, NJ

Track Institutional and Insider Activities on HEPA

Follow Hepion Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HEPA shares.

Notify only if

Insider Trading

Get notified when an Hepion Pharmaceuticals, Inc. insider buys or sells HEPA shares.

Notify only if

News

Receive news related to Hepion Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HEPA